FDA Clearance Tracker · P170039
CustomFlex Artificial Iris
Last checked: Nov 20, 2026Latest source record: May 30, 2018 (this decision)Source: openFDAMethods & limitations
Decided
May 30, 2018
Approved
Time to decision
182 days
Received Nov 29, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P170039
- Device name
- CustomFlex Artificial Iris
- Applicant
- Humanoptics AG
- Applicant location
- Erlangen
- Received
- Nov 29, 2017
- Decided
- May 30, 2018
- Decision
- Approved
- Supplements
- 3 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Artificial iris (QBT)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for the CustomFlex Artificial Iris. The CustomFlex Artificial Iris is indicated for use in children and adults for the treatment of full or partial aniridia resulting from congenital aniridia, acquired defects, or other conditions associated with full or partial aniridia.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QBT (Artificial iris).
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
Other decisions for Humanoptics AG
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.